Determining the best combination of TLR Agonist and Tumour Peptide for Cancer Vaccination

About this item

Title

Determining the best combination of TLR Agonist and Tumour Peptide for Cancer Vaccination

Content partner

University of Otago

Collection

Otago University Research Archive

Description

Immunotherapy has revolutionised the treatment of cancer in recent years; significantly improving patient response and long-term survival. Though many immunotherapies focus on increasing the effector function of immune cells, the ability to generate and stimulate new tumour-specific immune cells has become an important topic for patients who do not respond to first line therapy. Previous work in our laboratory identified that intracellularly reversible conjugation of mode antigen ‘Ovalbumin’(...

Read more

Format

Research paper

Research format

Scholarly text / Thesis

Thesis level

Masters

Date created

2017

Creator

Gaskarth, Douglas

URL

https://hdl.handle.net/10523/7735

Related subjects

Cancer / Tumour / Immunotherapy / Vaccine / Peptide

What is the copyright status of this item?

All Rights Reserved

This item is all rights reserved, which means you'll have to get permission from University of Otago before using it.

More Information

University of Otago has this to say about the rights status of this item:

All items in OUR Archive are provided for research purposes and private study and are protected by copyright with all rights reserved unless otherwise indicated.

What can I do with this item?

You must always check with University of Otago to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying

You are not allowed to adapt or remix this item into any other works.

No commercial use

You may not use this item commercially.